Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223

Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)

Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

LIVER FUNCTION TEST

Total Protein 7.62 gm% 6.3-8.4 gm% Biuret
Albumin 4.62 gm% 3.5-5.0 gm% BCG
Globulin 3 gm% 1.8-3.6 Serum, EIA
A/G Ratio 1.54 1.2 - 2.2 Serum, EIA
Bilirubin - Total 0.5 mg/dl <1.0 mg/dl Colorimetric
Bilirubin - Direct 0.16 mg/dl < 0.2 Colorimetric
Bilirubin - Indirect 0.34 mg/dL <0.4 mg/dl Serum, Calculated
Gamma GT 34.45 U/L 10-47
SGOT 60.4 U/L <46 Uv-kinetic
SGPT 64.56 U/L < 49 Uv-kinetic
Alkaline Phosphatase 47.19 U/L 30 - 120 PNPP-AMP
Buffer/Kinetic

**END OF REPORT**

Scan to Validate

Page 1 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

LIPID PROFILE
Cholesterol-Total 187 mg/dL Desirable level | < 200 Spectrophotometry
Borderline High | 200-239
High | >or = 240
Triglycerides 165.1 mg/dL Normal: < 150 Serum, Enzymatic,
Borderline High: 150-199 endpoint
High: 200-499
Very High: >= 500
HDL Cholesterol 38.38 mg/dL Normal: > 40 Serum, Direct
Major Risk for Heart: < 40 measure-PEG
LDL Cholesterol 115.60 mg/dL Optimal < 100 Enzymatic selective
Near / Above Optimal 100-129 protection
Borderline High 130-159
High 160-189
Very High >or = 190
VLDL Cholesterol 33.02 mg/dL 6 - 38 Serum, Enzymatic
CHOL/HDL Ratio 4.87 3.5 - 5.0 Serum, Enzymatic
LDL/HDL Ratio 3.01 2.5 - 3.5 Serum, Enzymatic
Note:
8-10 hours fasting sample is required.

**END OF REPORT**

Scan to Validate

Page 2 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

KIDNEY FUNCTION TEST

Urea 22.53 mg/dL 17 - 43 Uricase
BUN 10.52 mg/dL 7 - 18 Serum, Urease
Creatinine 0.91 mg/dL 0.67 - 1.17 Serum, Jaffe
Uric Acid 4.17 mg/dL 3.5 - 7.2 Serum, Uricase
Potassium 4.11 mmol/L 3.5 - 5.0
Premature cord: 5-10.2
Premature , 48 hrs: 3-6
Newborn cord: 5.6-12
Newborn: 3.7-5.9
Sodium 139.87 mmol/L 136 - 149
Premature, cord: 116-140
Premature 48 hrs: 128-148
Newborn cord: 126-166
Newborn: 133-146
Chlorides 102.09 mmol/L 101.00 - 109.00
Remark:
In blood, Urea is usually reported as BUN and expressed in mg/dl. BUN mass units can be converted to urea mass units by multiplying by 2.14.

**END OF REPORT**

Scan to Validate

Page 3 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

IRON PROFILE
Iron 78.1 µg/dL 65.00 - 175.00 PHOTOMETRY
UIBC 169.38 µg/dL 162 - 368
Total Iron Binding Capacity 247.48 µg/dL 225-535 PHOTOMETRY
Transferrin Saturation 31.56 % 13-45 Calculated
Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

**END OF REPORT**

Scan to Validate

Page 4 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

THYROID PROFILE TEST - TOTAL (T3,T4,TSH)

T3-Total 103.64 ng/dL 82 - 213
T4-Total 7.48 ug/dL 6.09 - 12.23
TSH-Ultrasensitive 2.52 uIU/mL 0.34 - 5.6 CLIA
Interpretation
TSH T3 T4 Suggested Interpretation for the Thyroid Function Tests Pattern

Raised Within Range Within Range .Isolated High TSHespecially in the range of 4.7 to 15 m1U/m1 is commonly
Raised Within range Within range associated with Physiological & Biological TSH Variability. Subclinical Autoimmune Hypothyroidism.Intermittent 14
therapy for hypothyroidism .Recovery phase after Non-Thyroidal illness"

Raised Decreased Decreased Chronic Autoimmune Thyroiditis Post thyroidectomy,Post radioiodine Hypothyroid phase of transient thyroiditis"

Raised or Raised or Interfering antibodies to thyroid hormones (anti-TPO antibodies)Intermittent 14 therapy or T4 overdose •Drug
Raised
within range within range interference- Amiodarone, Heparin,Beta blockers,steroids, anti-epileptics.

Raised or Raised or Isolated Low TSH -especially in the range of 0.1 to 0.4 often seen in elderly & Range Range associated with
Decreased
within range within range Non-Thyroidal illness .Subclinical Hyperthyroidism .Thyroxine ingestion'

Decreased Decreased Decreased Central Hypothyroidism .Non-Thyroidal illness .Recent treatment for Hyperthyroidism (TSH remains suppressed)"

Primary Hyperthyroidism (Graves' disease).Multinodular goitre, Toxic nodule •Transient thyroiditis:Postpartum, Silent
Decreased Raised Raised (lymphocytic), Postviral (granulomatous,subacute, DeQuervain's),Gestational thyrotoxicosis with hyperemesis
gravidarum"

Decreased
Raised Within range T3 toxicosis •Non-Thyroidal illness
Within Rang

Isolated Low T3-often seen in elderly & associated Non-Thyroidal illness In elderly the drop in 13 level can be upto
Within range Decreased Within range
25%.

**END OF REPORT**

Scan to Validate

Page 5 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

COMPLETE BLOOD COUNT (CBC)

Hemoglobin (Hb) 13.9 gm/dL 13.5 - 18.0
Erythrocyte (RBC) Count 5.37 mil/cu.mm 4.7 - 6.0
Packed Cell Volume (PCV) 44.1 % 42 - 52
Mean Cell Volume (MCV) 82.12 fL 78 - 100
Mean Cell Haemoglobin (MCH) 25.88 pg 27 - 31
Mean Corpuscular Hb Concn. 31.52 g/dL 32 - 36
(MCHC)
Red Cell Distribution Width (RDW) 17.8 % 11.5 - 14.0
Total Leucocytes (WBC) Count 6400 cell/cu.mm 4000-10000
Neutrophils 46 % 40 - 80
Lymphocytes 51 % 20 - 40
Monocytes 02 % 2 - 10
Eosinophils 1 % 1-6
Basophils 0 % 0-1
Absolute Neutrophil Count 2944 /c.mm 2000 - 7000
Absolute Lymphocyte Count 3264 /c.mm 1000 - 3000
Absolute Monocyte Count 128 /c.mm 200 - 1000
Absolute Eosinophil Count 64 /c.mm 20 - 500
Absolute Basophils Count 0 /c.mm 0 - 100
Platelet Count 219 10^3/ul 150 - 450
Mean Platelet Volume (MPV) 12.6 fL 7.2 - 11.7
PCT 0.28 % 0.2 - 0.5
PDW 16.4 % 9.0 - 17.0

**END OF REPORT**

Scan to Validate

Page 6 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

VITAMIN D (25 OH VITAMIN-D)

Vitamin D (25 - Hydroxy) 21.6 ng/mL Deficiency: < 20 Serum, CLIA
Insufficiency: 20 - <30
Sufficiency: 30 - 100
Interpretation:
1. Vitamin D is a fat soluble vitamin and exists in two main forms cholecalciferol "(vitamin D3)" which is synthesized in skin from 7-dehydrocholesterol in response to sunlight exposure &
Ergocalciferol (vitamin D2) present mainly in dietary sources. Both cholecalciferol & Ergocalciferol are converted to 25(OH) vitamin D in liver.
2. Testing for 25(OH) vitamin D is recommended as it is the best indicator of vitamin D nutritional status as obtained from sunlight exposure & dietray "intake". "Diagnosis of vitamin D
deficiency has clinical correlation with serum 25(OH) vitamin D, serum calcium, serum PTH, and serum alkaline phosphatase."

**END OF REPORT**

Scan to Validate

Page 7 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

GLYCOSYLATED HB (HBA1C)
HbA1c (GLYCOSYLATED 6.31 % (HPLC, NGSP
HEMOGLOBIN), BLOOD certified)
Estimated Average Glucose : 134.40 mg/dL -
Interpretation
As per American Diabetes Association (ADA)

Reference Group HbA1c in %

Non diabetic adults >=18 years <5.7

At risk (Prediabetes) 5.7 - 6.4

Diagnosing Diabetes >= 6.5

Age > 19 years

Goal of therapy: < 7.0
Therapeutic goals for glycemic control Action suggested: > 8.0
Age < 19 years
Goal of therapy: <7.5
Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of <
7.0 % may not be appropriate.
Comments
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better
indicator of long term glycemic control as compared to blood and urinary glucose determinations.

ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL)

6 126

7 154
8 183

9 212

10 240

11 269

12 298

Scan to Validate

Page 8 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

**END OF REPORT**

Scan to Validate

Page 9 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

GLUCOSE - PPBS
Blood Glucose-Post Prandial 119.8 mg/dL 80 - 140 Hexokinase

**END OF REPORT**

Scan to Validate

Page 10 of 11
 Patient Name : ASIT KUMAR PANDA Patient ID / Billing ID : AwLCM6750p / 269223
Age / Sex : 36 Yrs 6 M / Male Specimen Collected at : Curebay(BBSR)
Ref. Doctor : SELF Sample Collected On : Jul 02, 2024, 12:30 p.m.
Organization Name : Curebay(BBSR) Registration On : Jul 02, 2024, 12:30 p.m.
Sample ID : 002201 Reported On : Jul 04, 2024, 12:25 p.m.
SRF ID : AwLCM6750p Date of Birth : 01-01-1988

TEST DONE OBSERVED VALUE UNIT BIOLOGICAL REFERENCE INTERVALMETHOD

GLUCOSE - FASTING (FBS)

Glucose fasting 103.2 mg/dL Normal: 70 - 105 Fluoride Plasma-F,
Impaired Tolerance: 100-125 Hexokinase
Diabetes mellitus: >= 126
(on more than one occassion)
(American diabetes association
guidelines 2018)

**END OF REPORT**

Scan to Validate

Page 11 of 11